These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37251671)

  • 1. Six-month periodic fasting does not affect somatosensory nerve function in type 2 diabetes patients.
    Kender Z; von Rauchhaupt E; Schwarz D; Tsilingiris D; Schimpfle L; Bartl H; Longo VD; Bendszus M; Kopf S; Herzig S; Heiland S; Szendroedi J; Sulaj A
    Front Endocrinol (Lausanne); 2023; 14():1143799. PubMed ID: 37251671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sciatic nerve fractional anisotropy and neurofilament light chain protein are related to sensorimotor deficit of the upper and lower limbs in patients with type 2 diabetes.
    Kender Z; Jende JME; Kurz FT; Tsilingiris D; Schimpfle L; Sulaj A; von Rauchhaupt E; Bartl H; Mooshage C; Göpfert J; Nawroth P; Herzig S; Szendroedi J; Bendszus M; Kopf S
    Front Endocrinol (Lausanne); 2023; 14():1046690. PubMed ID: 37008917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes.
    Lai YR; Chiu WC; Huang CC; Cheng BC; Kung CT; Lin TY; Chiang HC; Tsai CJ; Kung CF; Lu CH
    Neurophysiol Clin; 2024 Jul; 54(4):102982. PubMed ID: 38761793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography.
    Jende JME; Groener JB; Oikonomou D; Heiland S; Kopf S; Pham M; Nawroth P; Bendszus M; Kurz FT
    Ann Neurol; 2018 Mar; 83(3):588-598. PubMed ID: 29443416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
    Aso Y; Iijima T; Jojima T; Saito M; Tanuma D; Kase M; Sakurai S; Tomaru T; Usui I
    Postgrad Med; 2024 Apr; 136(3):318-324. PubMed ID: 38660919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes.
    Mooshage CM; Tsilingiris D; Schimpfle L; Seebauer L; Eldesouky O; Aziz-Safaie T; Hohmann A; Herzig S; Szendroedi J; Nawroth P; Heiland S; Bendszus M; Kurz FT; Kopf S; Jende JME; Kender Z
    Diabetologia; 2024 Feb; 67(2):275-289. PubMed ID: 38019287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance training improves nerve conduction and arterial stiffness in older adults with diabetic distal symmetrical polyneuropathy: A randomized controlled trial.
    Gholami F; Khaki R; Mirzaei B; Howatson G
    Exp Gerontol; 2021 Oct; 153():111481. PubMed ID: 34280509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Nerve Remodeling at 3-T MR Neurography Differs between Painful and Painless Diabetic Polyneuropathy in Type 1 or 2 Diabetes.
    Jende JME; Groener JB; Kender Z; Rother C; Hahn A; Hilgenfeld T; Juerchott A; Preisner F; Heiland S; Kopf S; Nawroth P; Bendszus M; Kurz FT
    Radiology; 2020 Feb; 294(2):405-414. PubMed ID: 31891321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis between plasma fibrinogen and nerve electrophysiological changes in type 2 diabetic peripheral neuropathy.
    Gu W; Li Z; Zhu X; Huang X; Zhang D; Jiang Y; Ye Z; Sun Y; Ao P; Zhang X; Cao Q; Wei L; Wang S
    Folia Neuropathol; 2023; 61(2):153-162. PubMed ID: 37587890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.
    Schamarek I; Herder C; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
    Eur J Endocrinol; 2016 Apr; 174(4):433-43. PubMed ID: 26733478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial.
    Bosi E; Bax G; Scionti L; Spallone V; Tesfaye S; Valensi P; Ziegler D;
    Diabetologia; 2013 Mar; 56(3):467-75. PubMed ID: 23238789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranirestat for the management of diabetic sensorimotor polyneuropathy.
    Bril V; Hirose T; Tomioka S; Buchanan R;
    Diabetes Care; 2009 Jul; 32(7):1256-60. PubMed ID: 19366965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.
    Ziegler D; Bönhof GJ; Strom A; Straßburger K; Karusheva Y; Szendroedi J; Roden M
    Brain; 2021 Nov; 144(10):3251-3263. PubMed ID: 34499110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.
    Dyck PJ; O'Brien PC; Litchy WJ; Harper CM; Klein CJ; Dyck PJ
    Diabetes Care; 2005 Sep; 28(9):2192-200. PubMed ID: 16123489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close relationship between cardiovagal function and sural sensory nerve action potential in type 2 diabetes.
    Lai YR; Huang CC; Chiu WC; Liu RT; Tsai NW; Wang HC; Lin WC; Cheng BC; Su YJ; Su CM; Hsiao SY; Wang PW; Chen JF; Ko JY; Lu CH
    Clin Neurophysiol; 2019 Jul; 130(7):1160-1165. PubMed ID: 31102989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory Phenotypes Provide Insight Into the Natural Course of Diabetic Polyneuropathy.
    Tsilingiris D; Schimpfle L; von Rauchhaupt E; Sulaj A; Seebauer L; Herzig S; Szendroedi J; Kopf S; Κender Ζ
    Diabetes; 2024 Jan; 73(1):135-146. PubMed ID: 37862374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.